Zymewire Blog

Best practice guides, webinars, product info and podcasts.

OUR LATEST

Zymewire Blog

Reach your prospects the first time: Announcing improvements to Contact Search

14 Feb, 2022
Laser-focused outreach outperforms generic messages and mass emails. That’s the guiding principle behind our update to Contact Search, released today. Read More

Recent Posts

What do big pharma companies spend on research & development?
What do big pharma companies spend on research & development?
31 Mar, 2022
Zymewire News
by Sean Cannon

We've been working hard on a new report, and today we're happy to share that it is now available through Outsourcing-Pharma! Our inaugural ...

Read More
Racolta: Stay up to date on Pharma/Biotech Events
Racolta: Stay up to date on Pharma/Biotech Events
31 Mar, 2022
Zymewire News
by Sean Cannon

A partner of ours, Racolta, recently launched their new website and we would like to share! Subscribers can stay notified of upcoming ...

Read More
Clinical Reconnections: Join Zymewire in Boston for DIA2018
Clinical Reconnections: Join Zymewire in Boston for DIA2018
31 Mar, 2022
Racolta
by Sean Cannon

Are you going to DIA in Boston this month? Do you like networking and complimentary drinks & appetizers? We do too! Join us at Clinical ...

Read More
Splurges & Sprees to kick off 2019
Splurges & Sprees to kick off 2019
31 Mar, 2022
Industry Articles
by Sean Cannon

Welcome to Zymewire’s newest blog series, Flagged Events: M&A, where we will be recapping some of the latest mergers & acquisition ...

Read More
February 2019 Buys
February 2019 Buys
31 Mar, 2022
Industry Articles
by Sean Cannon

Welcome back to Flagged Events: M&A, where we recap some of the latest mergers & acquisition activities across pharma for the month.

Read More
California Biotech Funding in August 2019
California Biotech Funding in August 2019
31 Mar, 2022
Industry Articles
by Sean Cannon

Welcome to the newest instalment of Flagged Events: Funding segment. We’ll cover a sample of the drug companies with funding announcements ...

Read More
Sponsor Pipeline Insights: The Most Active Drug Companies in New York
Sponsor Pipeline Insights: The Most Active Drug Companies in New York
31 Mar, 2022
Industry Articles
by Sean Cannon

We live in a time where lists make up much of the content that appears in our timelines each day. So, why not ride the wave? Everybody ...

Read More
Sponsor Pipeline Insights: The Most Active Drug Companies in the American Northeast
Sponsor Pipeline Insights: The Most Active Drug Companies in the American Northeast
31 Mar, 2022
Industry Articles
by Sean Cannon

For our latest edition of Sponsor Pipeline Insights, we’re taking a look at the Northeast USA. More specifically, we’re comparing sponsor ...

Read More
CPhI Worldwide 2018
CPhI Worldwide 2018
31 Mar, 2022
Zymewire News
by Sean Cannon

Last week, we had the pleasure of visiting sunny Madrid (at least any other week out of the year it’s supposed to be sunny) for one of ...

Read More
Sponsor Pipeline Insights: The Most Active Drug Companies in France
Sponsor Pipeline Insights: The Most Active Drug Companies in France
31 Mar, 2022
Industry Articles
by Sean Cannon

In our 3rd edition of Sponsor Pipeline Insights, we’re heading overseas to France, a growing hotbed for clinical activity in Europe. While ...

Read More
Pharma takes Philly: 2nd Annual CPhI North America
Pharma takes Philly: 2nd Annual CPhI North America
31 Mar, 2022
Racolta
by Sean Cannon

Philadelphia. A city steeped in rich history, and designated as the birthplace of the United States. Home of the Liberty Bell, the famous ...

Read More
M&A in May 2019
M&A in May 2019
31 Mar, 2022
Industry Articles
by Sean Cannon

Welcome back to Flagged Events: M&A, where we recap some of the latest mergers & acquisition activities across pharma for the ...

Read More
Massachusetts Biotech Funding in July 2019
Massachusetts Biotech Funding in July 2019
31 Mar, 2022
Industry Articles
by Sean Cannon

Welcome to the newest instalment of Flagged Events: Funding segment. We’ll cover a sample of the drug companies with funding announcements ...

Read More
Massachusetts Biotech Funding in June 2019
Massachusetts Biotech Funding in June 2019
31 Mar, 2022
Industry Articles
by Sean Cannon

Welcome to the newest segment of our Flagged Events series, Flagged Events: Funding. We’ll cover the drug companies with funding ...

Read More
Building your Sales Software Stack: Don't get Lost in the Noise
Building your Sales Software Stack: Don't get Lost in the Noise
31 Mar, 2022
Industry Articles
by Sean Cannon

The sheer number of available tools and solutions that saturate the market is enough to make your head spin. What’s even more staggering is ...

Read More
California Biotech Funding in July 2019
California Biotech Funding in July 2019
31 Mar, 2022
Industry Articles
by Sean Cannon

Welcome to the newest instalment of Flagged Events: Funding segment. We’ll cover a sample of the drug companies with funding announcements ...

Read More
Sponsor Pipeline Insights: The Most Active Drug Companies in Japan
Sponsor Pipeline Insights: The Most Active Drug Companies in Japan
31 Mar, 2022
Industry Articles
by Sean Cannon

Welcome back to Sponsor Pipeline Insights, where we pick regions around the world and examine the most active clinical study registrants. ...

Read More
Your market in your pocket
Your market in your pocket
31 Mar, 2022
Zymewire News
by Sean Cannon

It’s one thing to have deep insight into your industry to always know what’s going on with customers, both prospective or existing, but ...

Read More
California Biotech Funding in June 2019
California Biotech Funding in June 2019
31 Mar, 2022
Industry Articles
by Sean Cannon

Welcome to the newest instalment of Flagged Events: Funding segment. We’ll cover a sample of the drug companies with funding announcements ...

Read More
Keeping things fresh
Keeping things fresh
31 Mar, 2022
Zymewire News
by Sean Cannon

As you may have noticed, things are a little bit different around here. We recently launched a brand new blog website, which will hopefully ...

Read More
Bring out the Grad Attire: Zymewire Completes Creative Destruction Lab
Bring out the Grad Attire: Zymewire Completes Creative Destruction Lab
31 Mar, 2022
Zymewire News
by Sean Cannon

It has been an exciting time for us here at Zymewire as of late. Our team is expanding, we’ve had the chance to meet many new people during ...

Read More

Custom built for biotech and pharma

We are obsessed with finding new ways to help your business generate more qualified leads. Our human-verified AI scans thousands of documents every day, separates the signal from the noise, and delivers value in the form of actionable sales intelligence.